ImpaQt * Pilot study on cognitive performance levels of patients with chronic Q-fever or Q-fever Fatigue Syndrome

ImpaQt * Pilot study on cognitive performance levels of patients with chronic Q-fever or Q-fever Fatigue Syndrome - ImpaQt * Pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42926

Enrollment

100

Registered

2016-09-01

Start date

2016-11-21

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Q-fever

Interventions

Concentration

Long Term Impact

Memory

Q-fever

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Patients with chronic Q-fever or Q-fever Fatigue Syndrome and controls from the general population. The pilot study will be performed in a subgroup of patients and controls who gave consent in a previous study (ImpaQt study, CCMO * Nijmegen number *2015-1919*).

Exclusion criteria

Exclusion criteria: Patients with clinical depression (as measured with the Beck*s Depression Index in the ImpaQt study) will be excluded. Participants with medical conditions that cause cognitive dysfunction, (dementia, CVA or other brain injuries, etc .) as well as a history of major psychiatric disorders, will also be excluded.

Design outcomes

Primary

Measure	Time frame
Main study parameters/endpoints: The main study parameters will be cognitive performance, measured with several neuropsychological tests	—

Secondary

Measure	Time frame
-	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)